In addition, lipid raft enrichment of ACE2 facilitates SARS-CoV-2 entry, suggesting that dyslipidemia may not only represent a comorbidity but also potentiate viral infectivity (2, 67–69). Here, ACE2 is linked to metabolic syndrome.